John Heymach

University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology

SCHOLARLY PAPERS

5

DOWNLOADS

220

TOTAL CITATIONS

5

Scholarly Papers (5)

1.

Radiotherapy Augments Pembrolizumab Responses and Outcomes in Metastatic Non-Small Cell Lung Cancer: Pooled Analysis of Two Randomized Trials

Number of pages: 33 Posted: 29 Dec 2019
Netherlands Cancer Institute - Department of Thoracic Oncology, Shandong University - Department of Radiation Oncology, Netherlands Cancer Institute - Department of Thoracic Oncology, Cleveland Clinic - Department of Quantitative Health Sciences, University of Texas at Houston - Department of Biostatistics, Netherlands Cancer Institute, Erasmus University Rotterdam (EUR) - Cancer Institute, VU University Medical Center, VU University Medical Center, Allegheny Health Network - Allegheny General Hospital, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Diagnostic Radiology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and University of Texas at Houston - Department of Radiation Oncology
Downloads 81 (607,170)
Citation 4

Abstract:

Loading...

Radiotherapy, Anti-PD-1, Pembrolizumab, Pooled analysis, Metastatic Non-Small Cell Lung Cancer

2.

Deep Learning CT Signature Predicts Benefit from Immunotherapy in Metastatic NSCLC Independent of Standard Clinicopathological Markers

Number of pages: 32 Posted: 13 Jun 2022
University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, Stanford University - Department of Medicine, Stanford University - Department of Medicine, Baylor College of Medicine, Baylor University - Department of Medicine Epidemiology and Population Science, New York University (NYU) - Thoracic Oncology Program, Harvard University - Department of Radiology, Mayo Clinic - Florida - Division of Hematology and Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center - Department of Biostatistics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and Stanford University - Department of Radiation Oncology
Downloads 71 (648,045)

Abstract:

Loading...

Non-small cell lung cancer (NSCLC), Immune Checkpoint Inhibitors (ICIs), Imaging biomarkers, Computed Tomography (CT), Deep learning, Survival analysis

3.

Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis

Number of pages: 26 Posted: 29 May 2024
University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Michigan at Ann Arbor, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Investigational Cancer Therapeutics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - MD Anderson Cancer Center, Stanford University - Department of Radiation Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - Department of Pulmonary Medicine
Downloads 23 (989,135)

Abstract:

Loading...

immune checkpoint inhibitor, mortality, pneumonitis, interstitial lung abnormalities, Non-small cell lung cancer

4.

Phase II Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemo Naive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905, NCT01064648)

Number of pages: 27 Posted: 09 Oct 2018
University of Texas at Houston - MD Anderson Cancer Center, SWOG Statistical Center, University of Texas at Houston - Department of Translational Molecular Pathology, US Oncology Comprehensive Cancer Centers of Nevada, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Cancer Care Specialists of Illinois, Kaiser Permanente, Montana Cancer Consortium, University of Michigan at Ann Arbor - Medical School, SWOG Statistical Center, University of California, Davis - School of Medicine and University of California, Davis - School of Medicine
Downloads 23 (989,135)
Citation 1

Abstract:

Loading...

mesothelioma, cediranib, cisplatin, pemetrexed, SWOG0905

5.

MCT4-Dependent Lactate Secretion Suppresses Antitumor Immunity in LKB1-Deficient NSCLC

Number of pages: 50 Posted: 23 Sep 2022
University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Translational Molecular Pathology, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, New York University (NYU) - Thoracic Oncology Program, University of Texas at Dallas - Children’s Medical Center Research Institute, University of Texas at Dallas - Hamon Center for Therapeutic Oncology Research, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology
Downloads 22 (1,000,047)

Abstract:

Loading...

LKB1, lung adenocarcinoma, PD-1, immunotherapy resistance, lactate, MCT4, T cell activation, macrophage polarization, metabolism